When the COVID-19 pandemic hit in March 2020, we listened to the challenges and concerns of our clients. In response, we launched a comprehensive solution to ensure that their workplaces were COVID-19 safe.
Safeguard your workforce while maintaining productivity.
Our COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan to limit the possibility of workplace COVID-19 transmission among workers. Our COVID-19 solution integrates with your existing health and safety protocols.
Our team, led by pandemic response expert, Dr. William Lang, has created this program to keep your employees safe and healthy while ensuring maximum efficiency.
The Benefits of our COVID-19 Program
Lower risk of transmission among employees
Day-to-day operational stability
Reduced workforce downtime
Confident, more engaged workforce
Diminished COVID-related claims
Decreased risk of litigation
The positive impact of our pandemic safety program is clear.
of employees screened daily
managed potential exposures
man-days of work saved (so far!)
Cathy Engelbert, Commissioner, WNBA
“In order to pull off a successful WNBA season amid the COVID-19 pandemic where we had the entire league at a single location, we knew it would take a great medical partner to ensure that our priority of keeping all involved healthy and safe was not only met, but exceeded the expectations of multiple stakeholders (players, coaches, athletic trainers, team physicians, and team and league staff). The medical professionals from JobSiteCare, from the medical director, the sports medicine physicians and registered nurses on site, to round the clock consultation resources, including infectious disease specialists, put in countless hours, hard work and diligence to keep the WNBA family on site at IMG Academy healthy and safe. Whenever we needed them, 24/7, they were there to help us manage the complexities of the medical needs for an entire league during a highly competitive season. We could not have completed our successful season without their services and support, and we are so grateful to them for being true MVPs of the 2020 WNBA season.”
COVID-19 Blog & Updates
As of today, trials of the AstraZeneca/Oxford University vaccine have restarted in all participating countries except the US. This keeps all 3 major vaccine trials on track for data analysis some time next month.
AstraZeneca working in conjunction with the University of Oxford in the United Kingdom had a single test subject who developed a significant medical issue at some point after being given the immunization.
The biggest news this week is that both Dr. Stephen Hahn, Commissioner of the FDA, and Dr. Tony Fauci of the NIH both said that a limited Emergency Use Authorization for at least one of the vaccines could be issued as early as late October or early November.
Many of us are beginning to get a sense that we have fallen into a COVID-19 rhythm. That is both good and bad. The good is that people understand the basic concepts of risks – the risk of infection versus the risk of serious disease.
The first set of major schools to bring the student bodies back started over the last 7 to 10 days and it did not take long for outbreaks to develop. Unfortunately, these outbreaks generally have little to do with education and everything to do with the actions of 18-22-year-olds.
As we approach the latter part of the summer, people should be asking the question: “What will this year’s flu season look like?” A bad flu season, as we had 2 years ago, combined with COVID-19 would significantly run the risk of overwhelming the health system.
Statisticians continue to argue over the real number of COVID-19 deaths. There is evidence that the total number of deaths in the world is higher than 6000 per day, but there is also evidence that an overly broad definition of “COVID-19 death” is used in many locations.
Currently, the World Health Organization estimates that 16% of people infected with COVID-19 are asymptomatic and are still capable of transmission. The data also shows that up to 40% of novel coronavirus transmission comes from people who are asymptomatic.
At the beginning of this epidemic, the medical community made many assumptions about how this disease was transmitted. The community took what we knew about influenza viruses and initially assumed many characteristics to also be true of COVID-19 transmission.
Subscribe to Our Newsletter